LFX453

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LFX453, covering 2015-05-15 to 2018-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Efficacy Study of LFX453 in Actinic Keratosis Patients [Phase 2]